Click a link below to view the mailing archive as if it had been sent to you.
| 2015-01-31 12:15 | | AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan and more... |
| 2015-01-31 00:15 | | Stocks That Battle Cancer Were The Best-Performing Biotechs In January and more... |
| 2015-01-30 12:15 | | Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers and more... |
| 2015-01-30 00:15 | | Two New Biotech IPOs Debut Friday, One Deal Delayed and more... |
| 2015-01-29 12:15 | | Why too many clinical trials fail - and a simple solution that could increase returns on pharma RnD and more... |
| 2015-01-29 00:15 | | Drugmakers receive mysterious invites to White House and more... |
| 2015-01-28 12:15 | | AdvaMed claims 195,000 jobs lost to medical device tax and more... |
| 2015-01-28 00:15 | | Amgen profit beats forecasts and more... |
| 2015-01-27 12:15 | | Obama wants to pour $1.2B into antibiotic R&D and more... |
| 2015-01-27 00:15 | | GSK Expands Portfolio of Asthma/COPD Medicines in U.S. and more... |
| 2015-01-26 12:15 | | FDA Approves Prestalia's Hypertension Treatment and more... |
| 2015-01-25 12:15 | | Novartis And Roche: Well-Equipped To Face Franc Shock and more... |
| 2015-01-24 12:15 | | Sun Pharma open to fresh acquisitions: Dilip S Shanghvi and more... |
| 2015-01-24 00:15 | | Booming biotechs bank $2.7B in follow-on cash and more... |
| 2015-01-23 12:15 | | Belgium's UCB leans on RTP work force for epilepsy drug application and more... |
| 2015-01-23 00:15 | | Intuitive Surgical posts 4Q profit, results beat Street expectations and more... |
| 2015-01-22 12:15 | | J&J eyes long-acting boost for Invega franchise with quick FDA look at new formula and more... |
| 2015-01-22 00:15 | | Orexigen Scripts Continue Impressive Track and more... |
| 2015-01-21 12:15 | | State Of The Union Lights Up Biotech and more... |
| 2015-01-21 00:15 | | Salix Pharma Reportedly Exploring Sale; Stock Up and more... |
| 2015-01-20 12:15 | | U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent and more... |
| 2015-01-20 00:15 | | FirstWord Lists – The drugs that will shape 2015 and more... |
| 2015-01-19 12:15 | | Mylan Launches Generic Hepatitis B Treatment and more... |
| 2015-01-18 12:15 | | Drug companies to blame for antibiotic resistance, says pharmaceutical boss and more... |
| 2015-01-18 00:15 | | Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix and more... |
| 2015-01-17 12:15 | | Gilead's appeal for drug patent in India could see protracted case and more... |
| 2015-01-16 12:15 | | A New Dawn For Biotech? and more... |
| 2015-01-16 00:15 | | Biotech Rivalry Gets Nasty in Mudslinging Battle Over Data and more... |
| 2015-01-15 12:15 | | An inside look at the FDA's approach to speeding new drug approvals and more... |
| 2015-01-14 12:15 | | FDA clears new obesity device and more... |
| 2015-01-14 00:15 | | Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting and more... |
| 2015-01-13 12:15 | | Merck CEO Frazier credits Keytruda success to slim-down strategy and more... |
| 2015-01-13 00:15 | | Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger and more... |
| 2015-01-12 12:15 | | Pharma and biotech showcase at JP Morgan health conference and more... |
| 2015-01-12 00:15 | | Shire to Buy NPS for $5.2 Billion to Add Rare-Disease Medicines |
| 2015-01-11 12:15 | | India should develop an enforceable legal framework through the proposed IPR Policy: John Castellani and more... |
| 2015-01-11 00:15 | | Next-Generation Diabetes Drug Offers Great Growth Potential and more... |
| 2015-01-10 00:15 | | Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot and more... |
| 2015-01-09 12:15 | | Analyst’s Top 3 Biotech Picks for 2015 With Upside and Takeover Potential and more... |
| 2015-01-09 00:15 | | Anthem selects Gilead as primary supplier of hepatitis C drugs and more... |
| 2015-01-08 12:15 | | Pfizer, FDA in talks on prescription details for key breast cancer drug and more... |
| 2015-01-08 00:15 | | Isis launches a cardio subsidiary and recruits a Genzyme vet to run it and more... |
| 2015-01-07 12:15 | | Court to Decide Next Month on Actavis Tactic for its Alzheimer’s Drug and more... |
| 2015-01-07 00:15 | | Will Allergan Buy Help Actavis Extend Growth Streak? and more... |
| 2015-01-06 12:15 | | Gardasil HPV Vaccine Not Linked To Multiple Sclerosis Or Related Diseases and more... |
| 2015-01-06 00:15 | | Amid Turmoil at Raleigh's Biggest Pharma, Salix CEO Retires and more... |
| 2015-01-05 12:15 | | Stryker buys British hospital bed maker CHG and more... |
| 2015-01-05 00:15 | | Big pharma waits decision on cancer drugs and more... |
| 2015-01-04 12:15 | | Israeli biomed cos shun TASE for Nasdaq and more... |
| 2015-01-03 12:15 | | Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares and more... |
| 2015-01-03 00:15 | | Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff and more... |
| 2015-01-02 12:15 | | With Roche out the door, Chiasma is raising $56M to go it alone and more... |
| 2015-01-02 00:15 | | The Worst-Performing Biotech Stocks Of 2014 and more... |
| 2015-01-01 12:15 | | The Top IPOs Of 2014: Radius Health and Auspex Pharmaceuticals and more... |
| 2015-01-01 00:15 | | Pfizer Faces An Enormous Patent Cliff and more... |
